The Concizumab Pen-Injector is Easy to Use and Preferred by Hemophilia Patients and Caregivers: A Usability Study Assessing Pen-Injector Handling and Preference

Autor: Kahr Rasmussen N, Berg B, Christiansen ASL, Neergaard JS, Ter-Borch G, Hildebrand EA, Gonczi M, Sparre T

Publikováno v: Patient Preference and Adherence, Vol Volume 18, Pp 1713-1727 (2024)

Niklas Kahr Rasmussen,1 Birgitte Berg,2 Anne Sia Louise Christiansen,3 Jesper Skov Neergaard,1 Gitte Ter-Borch,2 Emily A Hildebrand,4 Maya Gonczi,4 Thomas Sparre1 1Medical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations

Externí odkaz: https://doaj.org/article/7a944b446eb241b7ad567dc617046786

HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY

Autor: Shapiro, AD, Abraham, A, Linari, S, Neergaard, JS, Odgaard-Jensen, J, Zaw, JJT, Tran, H, Fabbron, GG

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S458-S458

Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study.

Autor: Windyga J; Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Apte S; Sahyadri Speciality Hospital, Pune, India., Frei-Jones M; Pediatric Hematology-Oncology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Fujii T; Hiroshima University Hospital, Hiroshima, Japan., Lyu CJ; Yonsei University Severance Hospital, Seoul, Korea., Villarreal Martinez L; Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico., Sathar J; Hospital Ampang, Ampang, Selangor Darul Ehsan, Malaysia., Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Tran H; The Alfred Hospital, Melbourne, Victoria, Australia., Zozulya N; National Medical Center for Hematology, Moscow, Russia., Brown Frandsen R; Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Novo Nordisk A/S, Søborg, Denmark., Thaung Zaw JJ; Novo Nordisk A/S, Søborg, Denmark., Mahlangu J; University of the Witwatersrand and NHLS, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 Nov; Vol. 113 (5), pp. 631-640. Date of Electronic Publication: 2024 Jul 19.

Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study.

Autor: Tran H; Ronald Sawers Haemophilia Centre, The Alfred Hospital, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., von Mackensen S; Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Abraham A; Department of Hematology, Christian Medical College, Vellore, India., Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy., Hampton K; Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK., Knoebl P; Division of Hematology and Hemostasis, Department of Medicine 1, Medical University of Vienna, Vienna, Austria., Linari S; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy., Odgaard-Jensen J; Biostatistics HTA, Novo Nordisk A/S, Søborg, Denmark., Neergaard JS; Safety Surveillance CVD I, Novo Nordisk A/S, Søborg, Denmark., Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Thaung Zaw JJ; Medical & Science Rare Bleeding Disorders, Novo Nordisk A/S, Søborg, Denmark., Zulfikar B; Division of Pediatric Hematology-Oncology, Istanbul University Oncology Institute, Istanbul, Turkey., Shapiro A; Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2024 Jun 17; Vol. 8 (4), pp. 102476. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).

Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.

Autor: Neergaard JS; Nordic Bioscience A/S, Herlev, Denmark.; DTU Bioengineering, Technical University of Denmark, Kgs, Lyngby, Denmark., Dragsbæk K; Nordic Bioscience A/S, Herlev, Denmark.; DTU Bioengineering, Technical University of Denmark, Kgs, Lyngby, Denmark., Christiansen C; Nordic Bioscience A/S, Herlev, Denmark., Karsdal MA; Nordic Bioscience A/S, Herlev, Denmark., Brix S; DTU Bioengineering, Technical University of Denmark, Kgs, Lyngby, Denmark., Henriksen K; Nordic Bioscience A/S, Herlev, Denmark.

Publikováno v: PloS one [PLoS One] 2018 Apr 11; Vol. 13 (4), pp. e0194802. Date of Electronic Publication: 2018 Apr 11 (Print Publication: 2018).